Letters |

Ramipril and Risk of Diabetes

Darryl K. Potyk, MD
JAMA. 2002;287(2):186. doi:10.1001/jama.287.2.186.
Text Size: A A A
Published online


To the Editor: Dr Yusuf and colleagues,1 for the Heart Outcomes Prevention Evaluation (HOPE) study investigators, reported that patients with known vascular disease had lower risk of developing diabetes if they were given ramipril rather than placebo. The initial publication of the HOPE study2 reported a 22% decrease in the composite end point of myocardial infarction, stroke, or death from cardiovascular causes among high-risk patients treated with ramipril compared with placebo. There were also statistically significant decreases in each component of the composite end point as well. Similarly, that previous article reported results of preplanned subgroup analysis that showed ramipril to be of particular benefit in patients with diabetes mellitus, microalbuminuria, hypertension, and cardiovascular disease. The authors observed that a new diagnosis of diabetes mellitus was made less frequently in the treatment group compared with the placebo group.2


Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview




Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.